Patents Assigned to Isis Corporation
  • Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
    Publication number: 20120029049
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of superoxide dismutase 1, soluble. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding superoxide dismutase 1, soluble. Methods of using these compounds for modulation of superoxide dismutase 1, soluble expression and for treatment of diseases associated with expression of superoxide dismutase 1, soluble are provided.
    Type: Application
    Filed: January 10, 2011
    Publication date: February 2, 2012
    Applicant: Isis Corporation
    Inventors: C. Frank Bennett, Kenneth W. Dobie, Susan M. Freier